Regenerative medicine, including cell and gene therapies, is the fastest growing pipeline for new therapeutic submissions to the FDA. Nina Tandon is CEO and co-founder of EpiBone, the world’s first company growing living human bones for skeletal reconstruction. She is the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech. Nina has also been awarded Crain's New York, Forty Under 40; Ernst & Young, Winning Woman; and Goldman Sachs, 100 Most Intriguing Entrepreneurs. She has a Bachelor’s in Electrical Engineering from the Cooper Union, a Master’s in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, as well as an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.